JP Morgan Chase’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $897M | Sell |
2,285,832
-176,143
| -7% | -$74.5M | 0.05% | 299 |
|
|
2026
Q1 | $1.15B | Buy |
2,461,975
+102,755
| +4% | +$51.7M | 0.07% | 240 |
|
|
2025
Q4 | $1.1B | Sell |
2,359,220
-627,849
| -21% | -$291M | 0.07% | 254 |
|
|
2025
Q3 | $1.27B | Sell |
2,987,069
-292,265
| -9% | -$113M | 0.08% | 237 |
|
|
2025
Q2 | $1.26B | Sell |
3,279,334
-320,358
| -9% | -$115M | 0.08% | 232 |
|
|
2025
Q1 | $1.24B | Buy |
3,599,692
+678,628
| +23% | +$218M | 0.09% | 210 |
|
|
2024
Q4 | $877M | Buy |
2,921,064
+503,775
| +21% | +$176M | 0.07% | 267 |
|
|
2024
Q3 | $982M | Sell |
2,417,289
-15,259
| -0.6% | -$5.59M | 0.07% | 241 |
|
|
2024
Q2 | $782M | Sell |
2,432,548
-284,001
| -10% | -$92.3M | 0.06% | 271 |
|
|
2024
Q1 | $906M | Sell |
2,716,549
-193,131
| -7% | -$59M | 0.08% | 248 |
|
|
2023
Q4 | $788M | Sell |
2,909,680
-1,900,967
| -40% | -$470M | 0.08% | 249 |
|
|
2023
Q3 | $1.18B | Buy |
4,810,647
+354,376
| +8% | +$97M | 0.13% | 163 |
|
|
2023
Q2 | $1.35B | Sell |
4,456,271
-50,658
| -1% | -$14.1M | 0.15% | 153 |
|
|
2023
Q1 | $1.19B | Sell |
4,506,929
-266,093
| -6% | -$67.6M | 0.14% | 157 |
|
|
2022
Q4 | $1.15B | Buy |
4,773,022
+659,156
| +16% | +$148M | 0.15% | 151 |
|
|
2022
Q3 | $756M | Sell |
4,113,866
-314,965
| -7% | -$62.7M | 0.11% | 191 |
|
|
2022
Q2 | $744M | Sell |
4,428,831
-480,733
| -10% | -$103M | 0.1% | 206 |
|
|
2022
Q1 | $1.23B | Buy |
4,909,564
+535,754
| +12% | +$135M | 0.15% | 152 |
|
|
2021
Q4 | $1.12B | Buy |
4,373,810
+74,309
| +2% | +$18.2M | 0.13% | 176 |
|
|
2021
Q3 | $1.04B | Sell |
4,299,501
-900,189
| -17% | -$220M | 0.13% | 178 |
|
|
2021
Q2 | $1.07B | Buy |
5,199,690
+422,082
| +9% | +$86M | 0.13% | 181 |
|
|
2021
Q1 | $900M | Buy |
4,777,608
+2,522,089
| +112% | +$445M | 0.12% | 185 |
|
|
2020
Q4 | $371M | Buy |
2,255,519
+1,326,983
| +143% | +$194M | 0.05% | 343 |
|
|
2020
Q3 | $112M | Sell |
928,536
-207,340
| -18% | -$25.7M | 0.02% | 659 |
|
|
2020
Q2 | $110M | Buy |
1,135,876
+86,686
| +8% | +$9.01M | 0.02% | 625 |
|
|
2020
Q1 | $94.3M | Sell |
1,049,190
-385,118
| -27% | -$49.9M | 0.02% | 582 |
|
|
2019
Q4 | $212M | Buy |
1,434,308
+113,783
| +9% | +$15.3M | 0.04% | 416 |
|
|
2019
Q3 | $159M | Buy |
1,320,525
+276,787
| +27% | +$35.8M | 0.03% | 506 |
|
|
2019
Q2 | $140M | Sell |
1,043,738
-28,903
| -3% | -$3.65M | 0.03% | 566 |
|
|
2019
Q1 | $140M | Sell |
1,072,641
-191,075
| -15% | -$25.7M | 0.03% | 547 |
|
|
2018
Q4 | $157M | Sell |
1,263,716
-356,111
| -22% | -$47.8M | 0.04% | 477 |
|
|
2018
Q3 | $225M | Sell |
1,619,827
-46,511
| -3% | -$5.79M | 0.04% | 417 |
|
|
2018
Q2 | $171M | Sell |
1,666,338
-132,522
| -7% | -$13.4M | 0.04% | 481 |
|
|
2018
Q1 | $174M | Sell |
1,798,860
-597,743
| -25% | -$58M | 0.04% | 460 |
|
|
2017
Q4 | $211M | Sell |
2,396,603
-188,375
| -7% | -$15.1M | 0.04% | 409 |
|
|
2017
Q3 | $204M | Buy |
2,584,978
+645,075
| +33% | +$51.9M | 0.05% | 411 |
|
|
2017
Q2 | $169M | Sell |
1,939,903
-314,604
| -14% | -$26.6M | 0.04% | 440 |
|
|
2017
Q1 | $201M | Buy |
2,254,507
+15,672
| +0.7% | +$1.31M | 0.05% | 410 |
|
|
2016
Q4 | $166M | Sell |
2,238,835
-1,380,958
| -38% | -$103M | 0.04% | 434 |
|
|
2016
Q3 | $274M | Sell |
3,619,793
-821,620
| -18% | -$62.9M | 0.07% | 297 |
|
|
2016
Q2 | $342M | Buy |
4,441,413
+144,396
| +3% | +$11.4M | 0.09% | 257 |
|
|
2016
Q1 | $335M | Buy |
4,297,017
+986,764
| +30% | +$68.9M | 0.09% | 257 |
|
|
2015
Q4 | $224M | Sell |
3,310,253
-251,363
| -7% | -$17.5M | 0.06% | 357 |
|
|
2015
Q3 | $276M | Sell |
3,561,616
-300,846
| -8% | -$26.6M | 0.07% | 280 |
|
|
2015
Q2 | $350M | Buy |
3,862,462
+203,502
| +6% | +$16.3M | 0.08% | 267 |
|
|
2015
Q1 | $275M | Buy |
3,658,960
+934,587
| +34% | +$67.1M | 0.06% | 339 |
|
|
2014
Q4 | $200M | Buy |
2,724,373
+576,079
| +27% | +$40.5M | 0.05% | 413 |
|
|
2014
Q3 | $151M | Buy |
2,148,294
+414,852
| +24% | +$27.4M | 0.04% | 488 |
|
|
2014
Q2 | $97.7M | Buy |
1,733,442
+394,345
| +29% | +$20.8M | 0.02% | 588 |
|
|
2014
Q1 | $70.3M | Buy |
1,339,097
+797,527
| +147% | +$39.7M | 0.02% | 664 |
|
|
2013
Q4 | $25.8M | Sell |
541,570
-35,917
| -6% | -$1.66M | 0.01% | 1178 |
|
|
2013
Q3 | $24.7M | Sell |
577,487
-60,525
| -9% | -$2.36M | 0.01% | 1185 |
|
|
2013
Q2 | $23M | Buy |
+638,012
| New | +$24.7M | 0.01% | 1171 |
|
Other funds holding HCA
CAM
JP Morgan Chase's HCA Position: Q2 2026 in Review
JP Morgan Chase reduced its HCA Healthcare (HCA) stake by 7.2% in Q2 2026, selling an estimated $74.5M and leaving 2,285,832 shares worth $897M. The position accounts for 0.05% of the portfolio, ranked #299.
JP Morgan Chase first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.35B in Q2 2023. 986 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- JP Morgan Chase held 2,285,832 shares of HCA Healthcare worth $897M as of Q2 2026.
- JP Morgan Chase sold 176,143 HCA Healthcare shares in Q2 2026, an estimated $74.5M.
- HCA Healthcare made up 0.05% of JP Morgan Chase's portfolio in Q2 2026, its #299 holding.
- JP Morgan Chase first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's HCA Healthcare position peaked at $1.35B in Q2 2023.
- 986 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.